Distribution, Elimination, and Renal Handling of 99mTechnetium-Demogastrin 1

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Biotherapy and Radiopharmaceuticals

• Publication date

  2012-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1089/cbr.2011.1008PMID 22409267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distribution and elimination characteristics of111In-DTPA-D-Phe1-octreotide and111In-DTPA-L-Phe1-octreotide in rats

  2010cited by this paper
• Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

  2010cited by this paper
• Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention

  2010cited by this paper
• Peptide receptor therapies in neuroendocrine tumors

  2009cited by this paper
• Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.

  2009cited by this paper
• Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma

  2009cited by this paper
• Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results.

  2009cited by this paper
• 99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo

  2009cited by this paper
• Tumor imaging and therapy using radiolabeled somatostatin analogues.

  2009cited by this paper
• Current status and perspectives in peptide receptor radiation therapy.

  2009cited by this paper
• Peptide-Based Probes for Cancer Imaging

  2008cited by this paper
• Biodistribution and elimination characteristics of two 111In-labeled CCK-2/gastrin receptor-specific peptides in rats.

  2007cited by this paper
• Selection of Radiolabeled Gastrin Analogs for Peptide Receptor–Targeted Radionuclide Therapy

  2007cited by this paper
• CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs.

  2005influential reference
• Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys.

  2005cited by this paper
• Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats

  2004cited by this paper
• Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives

  2003cited by this paper
• Lanreotide labeled with 99mTc: preparation, preclinical testing and comparison with (111)In-DTPA-octreotide.

  2002cited by this paper
• Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.

  2002cited by this paper
• Somatostatin and somatostatin analogues: diagnostic and therapeutic uses.

  2002cited by this paper
• New radiolabeled CCK-8 analogues [Tc-99m-GH-CCK-8 and Tc-99m-DTPA-CCK-8]: preparation and biodistribution studies in rats and rabbits.

  2001cited by this paper
• End-stage renal disease after treatment with 90Y-DOTATOC

  2001cited by this paper
• A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy.

  2001cited by this paper
• A review of the isolated kidney as an experimental model for pharmacokinetic studies.

  2000cited by this paper
• Pharmacokinetics and renal handling of 99mTc-labeled peptides.

  2000cited by this paper
• Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.

  1999influential reference
• High gastrin and cholecystokinin (CCK) gene expression in human neuronal, renal, and myogenic stem cell tumors: comparison with CCK-A and CCK-B receptor contents.

  1999cited by this paper
• Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin

  1998cited by this paper
• Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo

  1998cited by this paper
• Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.

  1997cited by this paper
• Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.

  1997cited by this paper
• Intracellular fate of radiometals.

  1997cited by this paper
• Unexpected high incidence of cholecystokinin‐B/gastrin receptors in human medullary thyroid carcinomas

  1996cited by this paper
• Clinical significance of gastrin receptors in human colon cancers.

  1989cited by this paper
• A new method for the determination of inulin in plasma and urine.

  1956cited by this paper

• Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics

  2018cites this paper
• Tetraamine-coupled peptides and resulting (99m)Tc-radioligands: an effective route for receptor-targeted diagnostic imaging of human tumors.

  2013cites this paper